Search Results - seigo+usuki

2 Results

Sort By:

Development of Peptide Mimics of GM1 Ganglioside

Tech ID: 2012-004 Title: Peptide Mimics for Treatment of GM-1 Associated Diseases Including Cholera and Guillain-Barre SyndromeCurrent State of the Art: Ganglioside GM1-associated diseases or infections are prevalent worldwide, and hundreds of millions of people are infected, or diagnosed, with ganglioside GM1-associated diseases each year. Exemplary...

Published: 6/19/2020 | Inventor(s): Robert Yu, Han-Chung Wu, Seigo Usuki

Keywords(s):

Category(s): Therapeutics

Development of Novel Therapies for Experimental Guillain-Barre Syndrome Using Ganglioside-Like Phage-Peptide

Current State of the Art:Guillain Barre syndrome is currently treated by administering pain relievers and other palliative forms of care to reduce the symptoms associated with the disease. Guillain Barre currently affects about 1 out of 50,000 people world-wide and in some instances has proven to be fatal due to limited treatments readily available...

Published: 4/28/2020 | Inventor(s): Robert Yu, Seigo Usuki

Keywords(s): Guillain-Barre, Phage-Peptide, Therapeutics

Category(s): Therapeutics